RevMedica Unveils Cutting-Edge Insight Technology for Surgeries at SAGES 2026

RevMedica, Inc., an innovative leader in medical technology, has announced that it will present its advanced real-time actionable insight technology at the upcoming Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2026 Annual Meeting. This prestigious event will be held from March 25 to 28, 2026, at the Tampa Convention Center in Tampa, Florida, and carries the theme "Connect to Purpose."

The highlighted technology from RevMedica is focused on enhancing the precision and safety of surgical procedures. By integrating objective intraoperative tissue sensing with physician assessments, the system significantly improves the accuracy of stapling cartridge selection, a critical aspect of soft tissue management. Through real-time data transmission at the moment of use, the technology aims to eliminate subjectivity in the surgical decision-making process, aiding surgeons in performing complex operations with higher assurance.

Tom Wenchell, the CEO and Co-Founder of RevMedica, expressed his enthusiasm about the acceptance of their abstract at SAGES 2026. He stated, “This endorsement reflects the growing necessity for objective, real-time data in operating rooms. Surgeons traditionally rely on subjective 'feel' when employing mechanical staplers; our objective is to replace this uncertainty with actionable insights that maximize clinical decision-making and elevate care standards for every patient.”

Steve Lampkin, the Chief Commercial Officer, elaborated, “Our hybrid platform collects crucial kinematic and tissue information during procedures. It’s much more than a smart stapler; it’s a unique data-driven surgical ecosystem that supplies relevant information just when surgeons need it most.” This capability highlights RevMedica's commitment not only to improving surgical outcomes but also to ensuring that healthcare providers have access to the best tools available.

This announcement comes at an opportune time as advancements in surgical technology become increasingly critical in a field that continuously seeks to enhance patient safety and operational efficiency. The integration of real-time data not only facilitates better decision-making during surgeries but also aligns with the industry's broader movement towards evidence-based medical practices.

RevMedica is supported by Telegraph Hill Partners and is at the forefront of revolutionizing approaches to surgical procedures involving soft tissues. The company is dedicated to bolstering clinical decision-making processes while enhancing patient safety by providing more efficient, eco-friendly surgical systems. Their innovations are steering towards creating a sustainable healthcare ecosystem that prioritizes patient outcomes through enabling technologies that yield superior clinical results.

It’s important to note that the devices discussed have not yet received FDA clearance for use in the United States. For more information about RevMedica and its pioneering technologies, visit revmedica.com.

As SAGES approaches, all eyes will be on the advancements showcased by firms like RevMedica, as they promise to significantly impact surgical practices, improve patient outcomes, and potentially reshape the landscape of surgical techniques in the years to come.